AKT1 and breast cancer: Knockdown of either Xist or SPEN expression in breast cancer cells suppressed the expression of PHLPP1, a phosphatase in AKT dephosphorylation [15], and was correlated with increased HDAC3 recruitment to the PHLPP1 promoter.